Challenges in Ras therapeutics in pancreatic cancer

M Choi, H Bien, A Mofunanya, S Powers - Seminars in cancer biology, 2019 - Elsevier
Pancreatic cancer is considered among the most aggressive and the least curable of all
human malignancies. It is usually characterized by multiple aberrations in tumor suppressor …
被引用次数：48 相关文章
[PDF] researchgate.net

[PDF][PDF] Challenges in Ras therapeutics in pancreatic cancer

M Choi, H Bien, A Mofunanya, S Powers - researchgate.net
Pancreatic cancer is considered among the most aggressive and the least curable of all
human malignancies. It is usually characterized by multiple aberrations in tumor suppressor …

Challenges in Ras therapeutics in pancreatic cancer.

M Choi, H Bien, A Mofunanya… - Seminars in Cancer …, 2017 - europepmc.org
Pancreatic cancer is considered among the most aggressive and the least curable of all
human malignancies. It is usually characterized by multiple aberrations in tumor suppressor …

Challenges in Ras therapeutics in pancreatic cancer

M Choi, H Bien, A Mofunanya… - Seminars in cancer …, 2019 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer is considered among the most aggressive and the least curable of all
human malignancies. It is usually characterized by multiple aberrations in tumor suppressor …
[PDF] researchgate.net

[PDF][PDF] Challenges in Ras therapeutics in pancreatic cancer

M Choi, H Bien, A Mofunanya, S Powers - researchgate.net
Pancreatic cancer is considered among the most aggressive and the least curable of all
human malignancies. It is usually characterized by multiple aberrations in tumor suppressor …